Product
Currency:CNY
2023/FY
Stock NameRevenueRatio
药物开发及商业化阶段的产品和服务1.38B79.96%
药物研究阶段的产品和服务345.25M20.01%
Other451.99K0.03%
Industry
Currency:CNY
2023/FY
Stock NameRevenueRatio
药物研发与生产相关业务1.73B100.00%
Region
Currency:CNY
2023/FY
Stock NameRevenueRatio
Abroad1.18B68.48%
Domestic543.7M31.52%
Other----